Cite Filings / IBRX / 0001193125-21-008222
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
425

Prospectus/Communication re Business Combination

ImmunityBio, Inc. · Filed 2021-01-13 · Acc 0001193125-21-008222

Documents 1

  • 425 Prospectus/Communication re Business Combination , d913919d425.htm

Around this filing

  • 2021-02-24 425 Prospectus/Communication re Business Combination
  • 2021-01-19 S-4 Registration Statement - Business Combination
  • 2021-01-13 4 Chief Financial Officer sold 16,364 shares at $15.00 ($245,460)
  • 2021-01-13 425 Prospectus/Communication re Business Combination
  • 2021-01-13 8-K Regulation FD disclosure
  • 2021-01-06 4 Chief Financial Officer sold 39,271 shares at $13.62 ($534,938)
  • 2020-12-22 425 Prospectus/Communication re Business Combination

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading d913919d425.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…